| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 7300 | DOTA |
7300.0010: 10 mg per vial 7300.0100: 100 mg per vial Please inquire for customized filling and bulk quantities. 
|
|
Cation complexation agent
|
||
| Molar Mass: 404.42 | ||
| C16H28N4O8 ⋅ H2O | ||
| [60239-18-1] | ||
| Colourless crystals packaged in dark glass screw cap vials. | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; 1H NMR spectrum |
||
|
Chemical Name: CA index name: 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid |
||
|
Synonymes: 1,4,7,10-Tetraazacyclododecane-N,N′,N′′,N′′′-tetraacetic acid; NSC 681107; Tetraxetan |
||
|
Literature: 1. Li W.P. et al. DOTA-D-Tyr1-Octreotate: A Somatostatin Analogue for Labeling with Metal and Halogen Radionuclides for Cancer Imaging and Therapy. Bioconjugate Chem. 2002, 13, 721-728. |
||
| 2. Traub T. et al. 111In-DOTA-Lanreotide Scintigraphy in Patients with Tumors of the Lung. J. Nucl. Med. 2001, 42, 1309-1315. | ||
| date of product catalogue issue: 05 April 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1